BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-κB activation

FEBS Letters

Volumn 584, Issue 5, 2010, Pages 865-872

  Ikeda, Osamu ^a   Miyasaka, Yuto ^a   Yoshida, Ryuji ^a   Mizushima, Akihiro ^a   Oritani, Kenji ^b   Sekine, Yuichi ^a   Kuroda, Makoto ^a   Yasui, Teruhito ^c   Fujimuro, Masahiro ^d   Muromoto, Ryuta ^a   Nanbo, Asuka ^a   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

BS69; EBV; LMP1; NF B; TRAF3; Transcription

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LATENT MEMBRANE PROTEIN 1; PROTEIN BS69; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERLEUKIN-6; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 76749123262     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.01.060     Document Type: Article

References (26)

1. Kieff E. Epstein-Barr virus and its replication. In: Field D.M., Knipe D.M., and Howley P.M. (Eds). Fields Virology. third ed. vol. 2 (1996), Raven Press, New York 2343-2396
2. Liebowitz D., Wang D., and Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol. 58 (1986) 233-237
3. Li H.P., and Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 10 (2003) 490-504
4. Huen D.S., Henderson S.A., Croom-Carter D., and Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10 (1995) 549-560
5. Laherty C.D., Hu H.M., Opipari A.W., Wang F., and Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem. 267 (1992) 24157-24160
6. Luftig M., Yasui T., Soni V., Kang M.S., Jacobson N., Cahir-McFarland E., Seed B., and Kieff E. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent non-canonical NF-κB activation. Proc. Natl. Acad. Sci. USA 101 (2004) 141-146
7. Brodeur S.R., Cheng G., Baltimore D., and Thorley-Lawson D.A. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem. 272 (1997) 19777-19784
8. Devergne O., Hatzivassiliou E., Izumi K.M., Kaye K.M., Kleijnen M.F., Kieff E., and Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activations. Mol. Cell. Biol. 16 (1996) 7098-7108
9. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., and Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA 93 (1996) 11085-11090
10. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., and Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80 (1995) 389-399
11. Izumi K.M., and Kieff E.D. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94 (1997) 12592-12597
12. Izumi K.M., Cahir McFarland E.D., Ting A.T., Riley E.A., Seed B., and Kieff E.D. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-κB activation. Mol. Cell. Biol. 19 (1999) 5759-5767
13. Wan J., et al. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway. Mol. Cell. Biol. 26 (2006) 448-456
14. Ikeda O., et al. STAP-2 negatively regulates both canonical and non-canonical NF-κB activation induced by Epstein-Barr virus-derived latent membrane protein 1. Mol. Cell. Biol. 28 (2008) 5027-5042
15. Hateboer G., Gennissen A., Ramos Y.F., Kerkhoven R.M., Sonntag-Buck V., Stunnenberg H.G., and Bernards R. BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J. 14 (1995) 3159-3169
16. Ansieau S., and Leutz A. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif. J. Biol. Chem. 277 (2002) 4906-4910
17. Ikeda O., et al. BS69 negatively regulates the canonical NF-κB activation induced by Epstein-Barr virus-derived LMP1. FEBS Lett. 583 (2009) 1567-1574
18. Kurozumi K., Nishita M., Yamaguchi K., Fujita T., Ueno N., and Shibuya H. BRAM1, a BMP receptor-associated molecule involved in BMP signalling. Genes Cells 3 (1998) 257-264
19. Sekine Y., et al. Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages. J. Immunol. 176 (2006) 380-389
20. Matsuda T., Yamamoto T., Muraguchi A., and Saatcioglu F. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J. Biol. Chem. 276 (2001) 42908-42914
21. Atkinson P.G., Coope H.J., Rowe M., and Ley S.C. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-κB2 p100 to p52. J. Biol. Chem. 278 (2003) 51134-51142
22. Eliopoulos A.G., Caamano J.H., Flavell J., Reynolds G.M., Murray P.G., Poyet J.L., and Young L.S. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene 22 (2003) 7557-7569
23. Saito N., et al. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-κB through distinct signaling pathways in fibroblast cell lines. J. Biol. Chem. 278 (2003) 46565-46575
24. Liao G., Zhang M., Harhaj E.W., and Sun S.C. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279 (2004) 26243-26250
25. Xie P., and Bishop G.A. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1. J. Immunol. 173 (2004) 5546-5555
26. Xie P., Hostager B.S., and Bishop G.A. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J. Exp. Med. 199 (2004) 661-671